HTN Cases Pharmacotherapy - 1. Case 1 TJ is a 45-year-old woman with a history of type 2 diabetes mellitus treated with glyburide 5 mg/ day. She.

Slides:



Advertisements
Similar presentations
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
Advertisements

JNC 8 Guidelines….
Review of the 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults – JNC 8 Eighth National Joint Committee Amanda Birnschein,
11/2/ Implications of ASCOT Results for ALLHAT Conclusions ALLHAT.
DIABETES AND THE KIDNEYS
UC-Irvine Internal Medicine Mini-Lecture Series
Efficacy of Sodium Bicarbonate Infusion in Reversal of Acute Renal Failure 1 NEPHRO 2014 June 25-28, 2014 Valencia, Spain.
The DRASTIC Trial. Dutch Renal Artery Stenosis Intervention Cooperative Reference van Jaarsveld BC, Krijnen P, Derkx FHM, et al. Resistance to antihypertensive.
Hypertension – Summary
Review cases 14-Apr SA is a 47 years old male who developed crushing substernal chest pain around 10 pm, he didn’t went to the hospital, in the.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Fluids and Electrolytes
MANAGEMENT HTN IN PREGNANCY. DEFINITIONS The definition of gestational hypertension is somewhat controversial. Some clinicians therefore recommend close.
Drugs for Hypertension
1 The JNC 7 recommendations for initial or combination drug therapy are based on sound scientific evidence.
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Illustrative Cases and Summary. A 50 year old European woman who is new to your practice comes to see you late on Friday afternoon with a sore throat.
Perioperative Testing
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
ACUTE STROKE — Hypertension is a common problem in patients with both type 1 and type 2 diabetes but the time course in relation to the duration.
Selection of Antihypertensive Drug. BP ClassificationSystolic BP, mm Hg Diastolic BP, mm Hg Normal
Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid- lowering Treatment to Prevent Heart.
Daily Dilemmas in Hypertension Management. Objectives Review the impact of hypertension on society Review the impact of hypertension on society Review.
Basma Y. Kentab. Aggressive comprehensive risk factor management: Improves survival, Reduces recurrent events and Reduces need for interventional procedures,
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
Blood pressure control in primary health care WORKSHOP
DION GALLANT, MD PRIMARY CARE SERVICE LINE MEDICAL DIRECTOR PRESBYTERIAN MEDICAL GROUP JNC 8.
Aminoglycoside-Induced Acute Tubular Necrosis PHCL 442 Lab Discussion 2 Raniah Al-Jaizani M.Sc.
Clinical Correlations The NYU Langone Online Journal of Medicine
Patient case studies. JR is a 72 YO male with CHF, LVEF=32%. T2DM, HTN His meds include carvedilol 12.5mg q12hr, furosemide 40mg q day, and kcl 20meq.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
-Greatest Achievements in Endocrinology – Jose Mario F. de Oliveira, MD, Ph.D. -Brigham&Womens Hospital – Endocrinology, Hypertension&Diabetes Division.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Hypertension & diabetes: new guidelines Janice Douglas, MD Case Western University Cleveland, OH George L Bakris, MD Director of the Hypertension/Clinical.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
CAD. Diagnosis  No single test can diagnose CHD. If your doctor thinks you have CHD, he or she may recommend one or more of the following tests.  EKG.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
7/27/2006 Outcomes in Hypertensive Black and Nonblack Patients Treated with Chlorthalidone, Amlodipine, and Lisinopril* * Wright JT, Dunn JK, Cutler JA.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
PHARMACOTHERAPY OF HYPERTENSION Based on New Guidelines Fariborz Nikaeen; MD Interventional cardiologist 2 november 2015.
Polypill x Aspirin Project Groups 3 and 4
Case I A 47 old male presents to your office for a yearly checkup. He smokes 40 cigarette/day, and examination detect wheezy chest and bronchospasm. His.
Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 
J.T. is a 62-year-old man with a history of CAD (MI 3 years ago), hypertension, depression, chronic renal insufficiency (baseline SCr is 2.8 mg/dL), peripheral.
1 ALLHAT Antihypertensive Trial Results by Baseline Diabetic Status January 28, 2004.
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
MACROVASCULAR COMPLICATIONS, DYSLIPIDEMIA and HYPERTENSION 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Therapeutics Conference. Fluid Resuscitation Early correction of fluid deficit is essential in hypovolemic shock to prevent decline in tissue perfusion.
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
HTN & CKD 1. HTN has been reported to occur in 85-95% of patients with CKD (stages 3–5). The relationship between HTN & CKD is cyclic in nature. Uncontrolled.
Case 2: Dyslipidaemia in Type 2 Diabetes Mellitus.
April 22, 2016 Connie Tien Daniel Kim Jeffrey Hughes Michelle Di Fiore
Case Presentation Done by: Lara Abbar Hadeel Al-Shareef Sarah Ghassal Raghad Bajaber Alia Al-Sayed Raghdah Mandili.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Angiotensin-Converting Enzyme Inhibitor–Associated.
Dr.M.shafiee Department of internal medicine Shiraz university of medical sciences.
+ Therapeutics 1 Tutoring Sarah Darby October 3, 2016.
Management of progression of CKD 순천향 대학병원 신장내과 강혜란.
Drugs for Hypertension
Udayan Bhatt, MD MPH OSU Nephrology
CAD.
HTN Cases Pharmacotherapy - 1.
How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients
Recent studies of ACE inhibition in renal disease
Section III: Neurohormonal strategies in heart failure
Table of Contents Why Do We Treat Hypertension? Recommendation 5
The following slides highlight a report by Dr
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
Presentation transcript:

HTN Cases Pharmacotherapy - 1

Case 1 TJ is a 45-year-old woman with a history of type 2 diabetes mellitus treated with glyburide 5 mg/ day. She presents to the clinic for a routine follow-up of her diabetes. Her BP today (average of two readings) is 138/88 mm Hg, HR is 70 beats/minute, Laboratory results are Na 140 mEq/L, K 4.0 mEq/L, Cl102 mEq/L, bicarbonate 28 mEq/L, BUN 14 mg/dL, and SCr 1.8 mg/dL. Of note, at her last visit, her BP was 136/85 mm Hg.

 What is the best for managing of her hypertension at this time? A.Begin lifestyle modifications. B.Begin lifestyle modifications and add amlodipine 5 mg/day. C.Begin lifestyle modifications and add lisinopril 2.5 mg/day. D.Begin lifestyle modifications and add atenolol 25 mg/day.

 The BP goal in individuals with diabetes mellitus or chronic renal dysfunction is less than 130/80 mm Hg. Despite the categorization of prehypertension, the presence of diabetes warrants immediate therapy to attain a more aggressive goal BP of less than 130/80 mm Hg than in the nondiabetic population.  The presence of diabetes presents a compelling reason to include an ACE inhibitor in the absence of any contraindication.

 Lisinopril initiated at a low dose of 2.5 mg/day is appropriate given her level of renal dysfunction and mildly elevated BP (Answer C). Although amlodipine could get the patient to her goal BP, this agent might not be as renal protective as an ACE inhibitor, making Answer B incorrect.  Likewise, no compelling indication is present for using a β-blocker in this patient; therefore, an atenolol-based regimen is less desirable than the ACE inhibitor regimen (Answer D). In all situations, lifestyle modifications should be emphasized to this patient (Answer A); however, additional drug therapy is warranted for her.

Case 2 DW is a 50-year-old African man being discharged from the hospital after an acute MI. His medical history is significant for hypertension. He was taking hydrochlorothiazide 25 mg/day before hospitalization. An echocardiogram before discharge shows an LVEF of more than 60%. His vital signs include BP 150/94 mm Hg and HR 80 beats/minute. Which one of the following is the best approach for managing his hypertension?

Which one of the following is the best approach for managing his hypertension? A. Discontinue hydrochlorothiazide and add diltiazem. B. Continue hydrochlorothiazide and add metoprolol. C. Discontinue hydrochlorothiazide and add losartan. D. Continue hydrochlorothiazide and add losartan. * SOAP this case

 With his history of MI, this patient has a goal BP of less than 130/80 mm Hg and a compelling reason to have a β-blocker as part of his antihypertensive regimen. In general, African Americans do not respond as well as whites to the antihypertensive effects of β-blockade; however, it should still be used.  The maintenance of hydrochlorothiazide in his regimen increases the likelihood of adequate BP control because African Americans typically respond well to diuretic therapy, bearing in mind that most individuals require two or more drugs to attain adequate BP control (Answer B).

The regimens without a β-blocker are inappropriate because of the patient's medical history of an acute MI. Therapy consisting of losartan (Answer C and Answer D) or diltiazem (Answer A) is inferior to β-blockade in this patient population.

Treatments that lower urinary albumin excretion may slow progression of diabetic kidney disease (DKD) and improve clinical outcomes, even in the absence of hypertension * * Kidney Disease Outcomes Quality Initiative

Thank you